What is the latest status of the project “AstraZeneca $50 Billion U.S. Manufacturing Expansion”?

The status recorded for “AstraZeneca $50 Billion U.S. Manufacturing Expansion” is planned.

What is the budget and commercial profile for the project “AstraZeneca $50 Billion U.S. Manufacturing Expansion”?

Taiyo normalizes the budget of “AstraZeneca $50 Billion U.S. Manufacturing Expansion” to USD 50000000000.

Where can I verify the source and access all details for “AstraZeneca $50 Billion U.S. Manufacturing Expansion”?

This Taiyo project page references AInvest along with the original URL (https://www.ainvest.com/news/astrazeneca-unveils-50-billion-manufacturing-expansion-tariff-pressures-2507/). Taiyo standardizes official data into a consistent, searchable project profile.

AstraZeneca $50 Billion U.S. Manufacturing Expansion

Sector: Manufacturing (Industrial) • Location: Virginia, United States

Source: AInvest

Project

Planned

AstraZeneca plans to invest $50 billion by 2030 to expand its manufacturing and research footprint in the U.S. This includes a new multi-billion-dollar drug substance manufacturing facility in Virginia focused on weight management and metabolic therapies, expansion of R&D facilities in Maryland and Massachusetts, and new manufacturing sites in Indiana, Texas, California, and Maryland. The investme

Status: Prospective
Sector: Manufacturing (Industrial)
Location: Virginia, United States of America
Updated: 22 Jul 2026
Source: AInvest

ConstructChat

Ask ConstructChat about AstraZeneca $50 Billion U.S. Manufacturing Expansion

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “AstraZeneca $50 Billion U.S. Manufacturing Expansion” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Virginia, United States. Taiyo aggregates data on it from AInvest.

Participants

Not available for this record.

Status

Original status	planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	AstraZeneca plans to invest $50 billion by 2030 to expand its manufacturing and research footprint in the U.S. This includes a new multi-billion-dollar drug substance manufacturing facility in Virginia focused on weight management and metabolic therapies, expansion of R&D facilities in Maryland and Massachusetts, and new manufacturing sites in Indiana, Texas, California, and Maryland. The investment aims to create skilled jobs and support advanced therapies, leveraging technologies like AI and automation.
Original sector	Health Care
Budget

Location

Country	United States of America (USA)
State	Virginia

Source

Source	AInvest
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2025-09-16

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

AstraZeneca $50 Billion U.S. Manufacturing Expansion

Ask ConstructChat about AstraZeneca $50 Billion U.S. Manufacturing Expansion

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States